Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inspire appoints new senior VP

This article was originally published in Scrip

Executive Summary

Inspire Pharmaceuticals, a US-based biopharmaceutical company focused on the R&D of prescription medicines for ophthalmic and pulmonary diseases, has appointed Robert Savel as senior vice-president and chief technical officer. He previously served as president of Savel Enterprises and has held senior management posts at PDL Biopharma and Johnson & Johnson. In his new position at Inspire, Mr Savel will join efforts to prepare for the company's potential commercial launch of denufosol tetrasodium for cystic fibrosis. The position will be effective from 20 September.

Topics

Related Companies

UsernamePublicRestriction

Register

SC010108

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel